tiprankstipranks
Avivagen Inc (TSE:VIV)
TSXV:VIV

Avivagen (VIV) Financial Statements

3 Followers

Avivagen Financial Overview

Avivagen's market cap is currently ―. The company's EPS TTM is C$-0.06; its P/E ratio is -0.17; Avivagen is scheduled to report earnings on June 4, 2024, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
Jul 23Apr 23Jan 23Oct 22Jul 22
Income Statement-
Total RevenueC$ 40.52KC$ 77.68KC$ 66.04K-C$ 48.61K
Gross ProfitC$ 23.79KC$ 24.79KC$ 30.76K-C$ 21.93K
EBITC$ -424.44KC$ -782.42KC$ -700.57K-C$ -1.47M
EBITDAC$ -419.12KC$ -767.08KC$ -680.21K-C$ -1.45M
Net Income Common StockholdersC$ -932.92KC$ -1.24MC$ -1.15M-C$ -1.90M
Balance Sheet-
Cash, Cash Equivalents and Short-Term InvestmentsC$ 17.18KC$ 17.19KC$ 26.68K-C$ 494.81K
Total AssetsC$ 272.53KC$ 324.69KC$ 568.30K-C$ 1.66M
Total DebtC$ 7.24MC$ 6.77MC$ 6.41MC$ 0.00C$ 5.80M
Net DebtC$ 7.22MC$ 6.75MC$ 6.38MC$ 0.00C$ 5.30M
Total LiabilitiesC$ 9.54MC$ 8.63MC$ 7.68M-C$ 6.92M
Stockholders EquityC$ -9.27MC$ -8.31MC$ -7.11M-C$ -5.26M
Cash Flow-
Free Cash FlowC$ 71.82KC$ 57.41KC$ -130.32K-C$ -1.14M
Operating Cash FlowC$ 71.82KC$ 57.41KC$ -130.32K-C$ -1.14M
Investing Cash Flow----C$ 0.00
Financing Cash FlowC$ -71.22KC$ -67.21KC$ -133.76K-C$ 168.11K
Currency in CAD

Avivagen Earnings and Revenue History

Avivagen Debt to Assets

Avivagen Cash Flow

Avivagen Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis